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Abstract
Background: In developing countries, post-operative pain remains underestimated and undertreated due to economic con-
straints, lack of  awareness and limited resources. In contrast, ketamine is an effective, readily available, easy to use and inexpen-
sive drug frequently used in poor settings.
Objectives: The aim of  this study was to explore the overall reduction in the medication treatment cost of  acute post-operative 
pain by adding intra-operative low-dose ketamine to traditional intravenous morphine for surgery in a low-income country.
Methods: A double blind randomized controlled trial with placebo-controlled parallel group was performed in Mulago Na-
tional Hospital (Uganda). Consenting adults scheduled for elective surgery were randomized into two study arms: Group K 
received ketamine 0.15mg/kg bolus at induction and a continuous infusion of  0.12 mg/kg/hour till start of  skin closure; Group 
C (control) received normal saline. Both groups received Morphine 0.1 mg/kg IV at debulking. The total medication cost was 
registered. NRS pain scores and other measurements such vital signs and incidence of  major and minor side effects were also 
recorded.
Results: A total of  46 patients were included. Patients’ baseline characteristics were comparable in both groups. No statistically 
significant difference was found between the groups concerning the overall medication cost of  post-operative pain management. 
Pain scores, patients’ satisfaction in the first 24 hours after surgery and hospital length of  stay were similar in both groups.
Conclusion: Our results do not support the utilization of  intra-operative low dose ketamine as a cost-saving post-operative pain 
treatment strategy for all types of  surgery in low-resource settings.
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Introduction
In low-income countries, the cost of  perioperative inter-
ventions represents one of  the main barriers for accessing 
essential surgical care1. In these settings, post-operative 
pain remains extremely underestimated and undertreated 
mainly due to procurement difficulties and the prohibi-
tive costs of  common analgesic medications.2-9
Ketamine is an anesthetic drug frequently used in low-re-
source settings as it is safe, easy to use and inexpen-
sive10,11. Ketamine has been increasingly used in sub-an-
esthetic doses as an adjuvant to opioids for acute pain 
management12-19. The balance of  evidence in the current 
literature demonstrates that low-dose ketamine given as 
pre-emptive analgesia, reduces post-operative pain and 
morphine consumption and delays the patients’ request 
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for rescue analgesia13,18-22. However, whether this reduc-
tion in the consumption of  analgesic drugs entails also 
a significant decrease in the costs of  post-operative pain 
management is unknown.
The aim of  this study was to compare the overall medi-
cation cost of  acute post-operative pain management in 
the first 24 hours when adding intra-operative low-dose 
ketamine to intravenous morphine after surgery in a 
low-income country. It was hypothesized that the over-
all medication cost would be lower for patients receiving 
ketamine compared with placebo.
Methods
This manuscript adheres to the CONSORT guidelines 
for randomized trials.
Ethical approval
This study was approved by the Makerere University's In-
stitutional Review Board (IRB #43, October 23rd, 2013) 
and written informed consent was obtained from all sub-
jects participating in the trial. The trial was registered pri-
or to patient enrollment at the Pan African Clinical Trials 
Registry (PACTR201410000854305, Principal investiga-
tor: Dr. Luca Ragazzoni, Date of  registration: October 
1, 2014).
Study design
This study was a double blind randomized controlled 
trial with placebo-controlled parallel group (single cen-
ter-based randomization (1:1)) conducted at the Mulago 
National Hospital, Uganda. Patients were randomly as-
signed to one of  the two parallel groups in 1:1 ratio to 
receive either intra-operative low-dose ketamine (Group 
K) or a control solution of  normal saline (Group C). Pa-
tients were randomly assigned to Group K or Group C, 
received intended treatment and were analyzed for out-
comes (Fig. 1). An independent data monitoring commit-
tee reviewed the blinded data for patient safety.
Study setting and population
Forty-six patients, 23 males and 23 females, scheduled for 
elective surgery under general anesthesia in the Mulago 
Hospital were enrolled between March and May 2014. All 
patients met the following inclusion criteria: 18-70 years 
old, ASA physical status I and II and acute or chronic 
disease requiring surgery under general anesthesia.
Patients with chronic pain under regular treatment with 
pain killers, alcohol and drug abuse cases, obese (BMI>30) 
subjects, neurosurgery, obstetrics and gynecology cases, 
patients too sick to communicate, and patients with psy-
chiatric disorders were excluded from the study.
As per agreement with the local authorities, the following 
general rules for stopping the study at any time were set: 
withdrawal of  patient’s consent, serious adverse effects 
and/or unacceptable safety incidents, any case of  new ex-
ternal information arisen during the conduct of  the study 
that either convincingly answered the primary study ques-
tion or that raised serious safety issues.
Randomization
An equal number of  envelopes for each treatment group 
were prepared using a computerized random number 
generator by a study assistant who did not take part in any 
subsequent part of  the study, and was not in contact with 
the rest of  the study team throughout the entire study du-
ration. He prepared 46 identical sequentially numbered, 
opaque, sealed and stapled envelopes; 23 envelopes con-
tained instructions for mixing solutions for Group K, and 
the other 23 for Group C. The envelopes were kept in a 
file with the principal investigator.
After a patient was recruited by a member of  the study 
team, a second study assistant selected an envelope ran-
domly from the file and mixed the study solution accord-
ing to the instructions in the envelope as per the patient’s 
weight. He then resealed the envelope, placed it in a dif-
ferent file, and gave the study solutions labeled with the 
patient identity code (the same as that on the selected 
envelope) to the anesthesiologist in charge; thereafter, he 
did not partake in any subsequent part of  the study. Both 
ketamine and normal saline study solutions had the same 
physical properties: clear liquids with no distinctive odor. 
Therefore, they could not be identified or differentiated 
by sight or smell by anyone in the operating theatre.
The allocation sequence was concealed from both the 
study team and study assistants. The blinded study team 
labeled the data collection sheet with the patient identity 
code, and, in the operating theatre, verified the proper 
timing of  study solution administration.
Study protocol
Theater lists were reviewed on the day before surgery and 
eligible patients noted. On the day of  surgery, a member 
of  the study team evaluated the patient in the waiting area 
of  the operation theater. Study details were explained to 
those who met the inclusion criteria. After obtaining writ-
ten informed consent, patients were made familiar with 
the Numeric Rating Scale (NRS) with a pain intensity 
scale ranging from “0” (no pain) to “10” (worst possible 
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pain). Patients were then randomized and allocated to the 
two groups according to the procedures previously de-
scribed.
A baseline set of  physiological parameters (weight, 
height, non-invasive blood pressure, oxygen saturation, 
respiratory rate and heart rate) was measured for each pa-
tient in the waiting area. Anesthetic pre-medication was 
given in the operating theater and consisted of  ranitidine 
50 mg, metoclopramide 10 mg, and fentanyl 2 μg/kg, all 
administered IV. Anesthesia was induced with propofol 
2 mg/kg and tracheal intubation was facilitated with suc-
cinylcholine 1 mg/kg. Patients were maintained with iso-
flurane inhaled at an end-tidal concentration of  1.5–2.5% 
in 50% oxygen/air mixture, fentanyl 1-2 mcg/kg/h and 
atracurium when needed.
Immediately after the induction of  anesthesia, a bolus 
dose of  0.15 mg/kg of  ketamine was injected to the pa-
tients in Group K, following the similar protocol pro-
posed by Parikh et al.19, while the same volume of  normal 
saline was given to the patients in Group C. The bolus 
dose was then followed, till the end of  skin closure, by 
a continuous infusion of  0.12 mg/kg/h of  ketamine in 
Group K and normal saline in Group C18. Morphine 0.1 
mg/kg IV was given at the end time of  debulking in both 
groups. No vital signs were recorded by the blinded ob-
server intra-operatively.
At the end of  surgery, the inhalation anesthetic was dis-
continued, and the residual neuromuscular blockade an-
tagonized with neostigmine 40 μg/kg and atropine 20 
μg/kg. Patients were extubated when reflexes, an ade-
quate breathing pattern and recovery of  muscle strength 
were restored. After surgery, all patients were monitored 
in the post-anesthesia care unit (PACU) for one hour to 
ensure a modified Aldrete score ≥ 9. During this time, a 
blind observer assessed the NRS pain score, vital signs 
and the incidence of  major and minor side effects.
If  NRS was ≥ 4, morphine was given as 2 mg increments 
until NRS <4. During the 4 hours between the sched-
uled assessments, a rescue dose of  diclofenac 50-75 mg 
or tramadol 50-100 mg was given if  requested by patients. 
During the 24 hours assessment all cases of  post-oper-
ative nausea and vomiting (PONV) were treated with 
metoclopramide 10 mg.
Outcome measures
Primary outcome
19 April 2014: 1 EUR= 3,470.84 UGX; 1 USD= 2,513.33 
UGX). The milligrams of  the analgesic drugs used for 
the single patients (morphine and ketamine) were noted, 
as well as the milligrams of  alternative analgesic drugs 
(diclofenac and tramadol) and of  drugs for PONV treat-
ment (metoclopramide). The overall cost was then cal-
culated adding together the total cost of  ketamine (6.60 
UGX per mg), morphine (203.00 UGX per mg), and ad-
ditional medications: tramadol (8.33 UGX per mg), di-
clofenac (0.34 UGX per mg) and metoclopramide (2.97 
UGX per mg).
Secondary outcomes
1.  Clinical evaluation: NRS pain scores, vital signs (heart 
rate, noninvasive blood pressure, respiratory rate and ox-
ygen saturation) and incidence of  major and minor side 
effects related to morphine administration such as respi-
ratory depression (respiratory rate <10 breaths/min), 
PONV and pruritus were assessed and measured every 
15 minutes during the first hour after surgery in PACU 
and every 4 hours during the consecutive 24 hours. Psy-
cho mimetic effects related to ketamine were also assed 
during the first hour after surgery.
2.  Analgesic acceptance: patients’ satisfaction was as-
sessed at the 24th hour by using a 4-point Likert scale (1 
“insufficient” to 4 “excellent”).
3.  Hospital length of  stay: patients were followed up 
from the day of  surgery to hospital discharge.
Data analysis
Before the study, the investigators hypothesized that the 
overall medication cost of  pain management of  patients 
who receive intra-operative low-dose ketamine would 
be 30% lower than that of  patients who do not receive 
ketamine. The primary outcome (measure of  the overall 
medication costs) was fit to a linear regression equation 
with four factors: group (Group K vs. Group C), ASA 
score, age, and gender. The null hypothesis of  all regres-
sion coefficients equal to zero was tested against the alter-
native hypothesis that some coefficients were not equal to 
zero. P-values less than 0.05 were considered significant 
for all statistical tests.
A sample size of  46 was chosen to give an 80% power 
of  detecting an effect size of  0.3 in the primary outcome. 
The software A-priori Sample Size Calculator for Multiple 
Regression1 was used to calculate the sample size23. Due 
to the small sample size of  this study, no interim analyses 
for efficacy or futility were done. During the trial, there 
were no changes made to the study methodology.
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Results
In the enrollment phase, 246 patients were assessed for 
eligibility; of  these, 196 did not meet the inclusion crite-
ria, two declined to participate, and two showed severe 
hypertension, resulting in a total of  200 patients excluded 
from the study (Fig.1). Among the 46 patients enrolled, 
23 were females and 23 were males; according to gender, 
patients were similarly distributed between the two study 
groups: 11 women and 12 men in Group K, 12 women 
and 11 men in Group C. Six patients, 4 in Group K and 
2 in Group C, were lost to follow-up, due to failure to 
register their discharge date on the file; therefore, only 40 
patients were assessed for hospital length of  stay.
 
       
   Figure 1: Participants & study flow chart 
Baseline characteristics with regard to age, weight, height, 
and duration of  infusion of  study solutions were equiv-
alent in the two study groups (Table 1). Surgical charac-
teristics (major and minor procedures) were comparable 
between both groups.
Table 2 shows a summary of  all elective procedures per-
formed during the research, which included general, oral, 
urologic and orthopedic surgery.
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Table 1. Baseline demographic and clinical characteristics for each group 
 
Variable Overall 
(mean±SD) 
Ketamine 
(mean±SD) 
Control 
(mean±SD) 
Mean 
difference 
p-value 
Age (years) 41.78±15.56 42.52±15.56 41.04±15.87 0.31 0.53 
Weight (kg) 62.76±12.25 60.69±9.5 64.82±14.39 1.08 0.13 
Height (cm) 164.18±8.52 165.31±8.40 162.66±8.72 0.91 0.63 
Duration of infusion 
(min) 114.67±49.72 109.13±53.98 120.21±45.60 0.75 0.78 
 
 
Table 2. Surgical procedures 
 
General Surgery n Oral Surgery n Urologic Surgery n Orthopedic Surgery     n 
 
Thyroidectomy 10 Tumor excision 9 Prostatectomy 2 ORIF* 21 
Mastectomy 5 (parotid or neck 
mass) 
1 Penis plication 
plasty 
1 TBW** 1 
Appendicectomy 4 Mastoidectomy 1 Uretheroplasty 1 Tumor excision 
(scapula) 
1 
Cholecistectomy 2 Caldwell Luc 1         
Choledocotomy 1 Lateral 
rhinotomy 
1         
Hemicolectomy 1 Timpanoplasty 1         
Splenectomy 1             
Mass excision 
(Laparotomy) 
1             
* Open Reduction Internal Fixation 
** Tension Band Wiring 
  
Primary outcome
The mean medication cost of  post-operative analgesia 
during the first 24 hours after surgery was 2586.86 UGX 
for Group K and 2844.74 UGX for Group C (Fig. 2). 
There was no statistically significant difference between 
the two groups (p=0.40) (95% CI for the difference: -769, 
+311) even after controlling for ASA, gender, and age. 
Data from all the 46 enrolled patients were available for 
this analysis. Mean consumption of  post-operative mor-
phine was 5.6 mg in Group K and 6.9 mg in Group C. 
Ten patients required additional analgesia, 3 in Group K 
and 7 in Group C (Table 3). One vial of  10 milligrams of  
metoclopramide was given to 5 patients in Group K and 
1 patient in Group C.
Table 3. No. of patients provided with additional analgesic medications 
  
  
  
  
Medication Group K Group C 
Tramadol 2 2 
Diclofenac 1 5 
Metoclopramide 5 1 
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         Figure 2: Overall cost for post-operative pain management 
Secondary outcomes
Clinical evaluation
Pain scores during the first 24 hours after surgery were 
comparable in the two groups with a mean value of  3.71 
in Group K and 3.91 in Group C. There was no statistical-
ly significant difference between the two groups (Fig. 3). 
Eight patients in Group K experienced vomiting, com-
pared to 4 patients in Group C. Three patients in each 
group had nausea, while one patient in each group had 
minor skin reaction. Neither major or other minor side 
effects nor psycho-mimetic effects related to ketamine 
were observed in post-operative period in both groups. 
In Group K, three patients reported nausea, eight vom-
iting and one suffered from pruritus. Similarly, in Group 
C, three patients reported nausea, four vomiting and one 
pruritus. In both groups no respiratory depression (RR< 
10 breaths/min) was observed.
 
  
Figure 3: 
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Analgesic acceptance
At the end of  the 24-hour pain assessment, 32 patients 
(69.6%) reported a satisfaction score of  4 (excellent), 
while the remaining 14 (30.4%) indicated a score of  3 
(very good). There was no statistically significant differ-
ence between the two groups (data not shown).
Hospital length of  stay
Hospital length of  stay ranged from 1 to 30 days with a 
mean value of  8.2 and 4.2 days for Group K and Group 
C, respectively. There was no statistically significant dif-
ference between the two groups (p=0.24) (95% CI for 
the difference: -1.8 , 7.2) even after controlling for age, 
gender and ASA classification.
Discussion
This randomized controlled trial explored the overall 
medication cost of  acute post-operative pain treatment in 
the first 24 hours after surgery when intra-operative low-
dose ketamine was combined to intravenous morphine. 
To date, this research seems to be the first scientific ef-
fort to assess the influence of  ketamine in reducing the 
medication cost of  post-operative pain relief. Moreover, 
it represents an attempt to define a feasible method to 
treat post-operative acute pain in settings characterized 
by limited medical resources, such as developing coun-
tries or disaster situations.
This study failed to demonstrate a significant cost reduc-
tion of  post-operative pain management when pre-emp-
tive analgesia with low-dose ketamine was performed. 
Interestingly, the overall consumption of  morphine in 
the post-operative period was non-significantly differ-
ent in the two groups, in contrast with previously pub-
lished studies that supported ketamine’s opioid-sparing 
effect.12,19,24
Our results showed no difference in either post-opera-
tive pain intensity or patients’ satisfaction between the 
two groups in any of  the measurements performed. Pain 
scores were low in both groups, indicating the provision 
of  a satisfactory analgesic protocol and suggesting the ab-
sence of  additional effect on pain provided by ketamine. 
While several of  the above studies have demonstrated 
less post-operative pain in patients receiving pre-emptive 
analgesia with ketamine, others have reported no bene-
fit25-29.
A plausible explanation for these contradictory results 
could be ascribed to the broader presence of  major sur-
gery procedures in studies reporting no improvement of  
post-operative pain scores; in these cases, pre-operative 
ketamine might not have been able to stop central sensi-
tization21. Interestingly, in their meta-analysis of  random-
ized clinical trials, Yang et al.18 found little association be-
tween the pre-emptive dose of  ketamine and its analgesic 
efficacy after surgery. Remarkably, most of  the studies in-
cluded in this meta-analysis reported the absence of  any 
beneficial effect of  pre-emptive ketamine in improving 
pain scores in the late post-operative period (>12-24 h)12.
Regarding the need for additional analgesia, tramadol was 
equally administered in both groups while diclofenac was 
administered more frequently in control patients. There 
is little explanation for this fact as the administration of  
either of  these two drugs was left to the free will of  the 
health operator. Anecdotally, the study of  Wang et al. that 
was conducted in patients undergoing transurethral re-
section of  prostate, found a smaller request of  tramadol 
in the ketamine group21.
Our findings showed no statistical difference also in ma-
jor or minor side effects between study groups. Similar-
ly, other studies have already reported on the safety of  
pre-emptive analgesia with ketamine12,19-21. Specifically, 
the low doses used in this study would be responsible 
for the lack of  central nervous system symptoms such 
as hallucinations etc. It is remarkable that, while most of  
these studies have focused on a certain type of  surgery 
(e.g. abdominal surgery, orthopedic surgery, renal surgery 
etc.)12,19, our study embraced a fair variety of  surgical in-
terventions which may suggest ketamine as a safe drug 
regardless of  the surgical procedure.
The results of  our study showed no significant difference 
between the two groups regarding hospital length of  stay, 
indicating that pre-emptive ketamine has no impact on 
recovery profiles and patients’ functional outcome.
Of  note, Himmelseher and co-workers30 highlighted the 
limited availability of  long-term outcome measures in 
the current literature exploring the intra-operative use 
of  intravenous low-dose ketamine in general anesthesia. 
Therefore, more research is needed to better investigate 
the long-term effect of  pre-emptive ketamine. In sum-
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mary, the results of  this study do not support pre-emp-
tive analgesia with ketamine as a cost-effective strategy 
for all type of  surgery in low-resource settings. Moreover, 
pre-emptive low-dose ketamine did not show a significant 
opioid-sparing effect, nor improved post-operative pain 
scores and patients’ satisfaction. Further studies would be 
advisable in order to solidify or contradict our findings.
 
Limitations
The results of  this study must be tempered in light of  
some limitations. First, similarly to a preceding study30, 
it is possible that the inclusion of  patients from a variety 
of  medical procedures contributed to increased variance 
in patients' response to treatment. However, the aim of  
the present study was to assess the cost-effectiveness of  
ketamine not as procedure for a single type of  surgery 
but as a general pre-emptive analgesia strategy to be used 
in a low-resource setting. Second, it is well-known that 
preoperative low doses of  ketamine decrease the possibil-
ity of  the occurrence of  psychiatric/psychomimetic ef-
fects but could also be responsible for the negative results 
obtained. Third, the absence of  a consistently available 
translator may have led to some misunderstanding during 
pain score assessments preventing, sometimes, the cor-
rect evaluation of  the patient, especially during his/her 
recovery from anesthesia in the PACU. In addition, the 
primary outcome we assessed (overall medication cost in 
the first 24 hours after surgery) was quite limited. Quali-
ty-adjusted life years (QALY) for pain and/ or more time 
points could be considered in future studies or replicas. 
Finally, although, we assessed the occurrence of  psycho 
mimetic effects during the first hour after surgery, we 
couldn’t exclude the appearance of  late side effects relat-
ed with ketamine
Conclusion
This study demonstrated no statistically significant dif-
ference for all type of  surgery between patients receiving 
intra-operative low-dose ketamine and patients receiv-
ing normal saline in terms of  overall medication cost of  
post-operative pain management. Moreover, our findings 
do not support the opioid-sparing effect of  ketamine. 
There was no difference between the two groups in pain 
scores during the first 24 hours, major or other minor 
side effects, patients’ satisfaction and hospital length of  
stay.
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